Ginny D. Ho

667 citations

22 papers · 458 indexed · h-index 13

Molecular Biology
Cellular and Molecular Neuroscience top 10%
Organic Chemistry
Pharmacology top 10%
Physiology

Co-authors: Deen Tulshian Ahmad Fawzi Hongtao Zhang William J. Greenlee Robert A. Hodgson April Smith‐Torhan Shu‐Wei Yang Michael P. Graziano
Topics: Receptor Mechanisms and Signaling (14 papers)Neuropeptides and Animal Physiology (12 papers)Pharmacological Receptor Mechanisms and Effects (5 papers)
Cited by: Cellular and Molecular Neuroscience Pharmacology Physiology
Journals: Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics Molecular Pharmacology
Partner nations: United States United Kingdom Bulgaria

In The Last Decade

Ginny D. Ho

22 papers receiving 443 citations

Peers

Countries citing papers authored by Ginny D. Ho

Since Specialization

Citations

This map shows the geographic impact of Ginny D. Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ginny D. Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ginny D. Ho more than expected).

Fields of papers citing papers by Ginny D. Ho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ginny D. Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ginny D. Ho. The network helps show where Ginny D. Ho may publish in the future.

Co-authorship network of co-authors of Ginny D. Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Ginny D. Ho. A scholar is included among the top collaborators of Ginny D. Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ginny D. Ho. Ginny D. Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Discovery of pyrrolo-benzo-1,4-diazines as potent Nav1.7 sodium channel blockers 2014 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,Deen Tulshian,(unknown),Zheng Tan,(unknown),(unknown),Julius J. Matasi,(unknown),William G. Earley,(unknown),R. Jason Herr,Xiaoping Zhou,(unknown),Diane Rindgen,Steve Sorota,Shu‐Wei Yang	10
2	Bioavailable pyrrolo-benzo-1,4-diazines as Nav1.7 sodium channel blockers for the treatment of pain 2014 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,Ginny D. Ho,Deen Tulshian,(unknown),Zheng Tan,(unknown),(unknown),Julius J. Matasi,Xianfeng Sun,(unknown),R. Jason Herr,Xiaoping Zhou,(unknown),Mark O. Urban,Jeffrey A. Vivian,Diane Rindgen,Steve Sorota	13
3	The SAR development of dihydroimidazoisoquinoline derivatives as phosphodiesterase 10A inhibitors for the treatment of schizophrenia 2012 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,W. Michael Seganish,(unknown),Deen Tulshian,William J. Greenlee,(unknown),Alan Hruza,Li Xiao,Diane Rindgen,Deborra Mullins,M. Guzzi,Xiaoping Zhang,(unknown),Robert A. Hodgson	20
4	The discovery of potent, selective, and orally active pyrazoloquinolines as PDE10A inhibitors for the treatment of Schizophrenia 2011 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,Shu‐Wei Yang,(unknown),(unknown),Terry L. Nechuta,Elizabeth M. Smith,William T. McElroy,Zheng Tan,Deen Tulshian,Brian A. McKittrick,William J. Greenlee,Alan Hruza,Xiao Li,Diane Rindgen,Deborra Mullins,M. Guzzi,Xiaoping Zhang,(unknown),Robert A. Hodgson	28
5	The anxiolytic-like profile of the nociceptin receptor agonist, endo-8-[bis(2-chlorophenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octane-3-carboxamide (SCH 655842): Comparison of efficacy and side effects across rodent species 2011 ·European Journal of Pharmacology ·Sherry Lu,Guy A. Higgins,Robert A. Hodgson,Lynn A. Hyde,Robert A. Del Vecchio,(unknown),Tatiana M. Kazdoba,(unknown),Cynthia A. Morgan,(unknown),Ginny D. Ho,Deen Tulshian,Eric M. Parker,John C. Hunter,Geoffrey B. Varty	20
6	Discovery of orally active pyrazoloquinolines as potent PDE10 inhibitors for the management of schizophrenia 2011 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,(unknown),William T. McElroy,Zheng Tan,Ginny D. Ho,Deen Tulshian,William J. Greenlee,M. Guzzi,Xiaoping Zhang,Deborra Mullins,Li Xiao,Alan Hruza,Tze‐Ming Chan,Diane Rindgen,(unknown),Robert A. Hodgson	43
7	Pyrazoloquinolines as PDE10A inhibitors: Discovery of a tool compound 2011 ·Bioorganic & Medicinal Chemistry Letters ·William T. McElroy,Zheng Tan,Kallol Basu,Shu‐Wei Yang,(unknown),Ginny D. Ho,Deen Tulshian,William J. Greenlee,Deborra Mullins,M. Guzzi,Xiaoping Zhang,(unknown),Robert A. Hodgson	28
8	Identification of Two Novel Metabolites of SCH 486757, a Nociceptin/Orphanin FQ Peptide Receptor Agonist, in Humans 2010 ·Drug Metabolism and Disposition ·Natalia A. Penner,Ginny D. Ho,(unknown),Swapan K. Chowdhury,Kevin B. Alton	8
9	Structure–activity relationships of 2,4-diphenyl-1H-imidazole analogs as CB2 receptor agonists for the treatment of chronic pain 2010 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,(unknown),Julius J. Matasi,Ginny D. Ho,Deen Tulshian,William J. Greenlee,R. Brusa,Massimiliano Beltramo,Kathleen Cox	10
10	Effect of a Novel NOP Receptor Agonist (SCH 225288) on Guinea Pig Irritant-Evoked, Feline Mechanically Induced and Canine Infectious Tracheobronchitis Cough 2009 ·Pharmacology ·Robbie L. McLeod,Deen Tulshian,Ginny D. Ho,Xiomara Fernandez,Donald C. Bolser,Leonard E. Parra,(unknown),(unknown),Ahmad Fawzi,Huchappa Jayappa,(unknown),(unknown),April Smith‐Torhan,Hongtao Zhang,John A. Hey	11
11	Identification of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the management of cough and anxiety 2009 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,Ginny D. Ho,Deen Tulshian,William J. Greenlee,Zheng Lin Tan,Hongtao Zhang,April Smith‐Torhan,Ahmad Fawzi,John C. Anthes,Sherry Lu,Geoffrey B. Varty,Xiomara Fernandez,Robbie L. McLeod,John A. Hey	11
12	Discovery of Orally Active 3-Pyridinyl-tropane As a Potent Nociceptin Receptor Agonist for the Management of Cough 2009 ·Journal of Medicinal Chemistry ·Shu‐Wei Yang,Ginny D. Ho,Deen Tulshian,William J. Greenlee,John C. Anthes,Xiomara Fernandez,Robbie L. McLeod,John A. Hey,Xiaoying Xu	9
13	The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxiety 2009 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,John C. Anthes,(unknown),John P. Caldwell,Kuo-Chi Cheng,Xiaoming Cui,Ahmad Fawzi,Xiomara Fernandez,William J. Greenlee,John A. Hey,Walter A. Korfmacher,Sherry Lu,Robbie L. McLeod,(unknown),(unknown),Zheng Lin Tan,Deen Tulshian,Geoffrey B. Varty,Xiaoying Xu,Hongtao Zhang	19
14	The Anxiolytic-Like Effects of the Novel, Orally Active Nociceptin Opioid Receptor Agonist 8-[bis(2-Methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510) 2008 ·Journal of Pharmacology and Experimental Therapeutics ·Geoffrey B. Varty,Sherry Lu,Cynthia A. Morgan,Mary Cohen-Williams,Robert A. Hodgson,April Smith‐Torhan,Hongtao Zhang,Ahmad Fawzi,Michael P. Graziano,Ginny D. Ho,Julius J. Matasi,Deen Tulshian,Vicki L. Coffin,Galen Carey	67
15	Structure–activity relationships of 3-substituted N-benzhydryl-nortropane analogs as nociceptin receptor ligands for the treatment of cough 2008 ·Bioorganic & Medicinal Chemistry Letters ·Shu‐Wei Yang,Ginny D. Ho,Deen Tulshian,William J. Greenlee,Xiomara Fernandez,Robbie L. McLeod,(unknown),John C. Anthes	12
16	Synthesis and structure–activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 2 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,(unknown),Deen Tulshian,William J. Greenlee,Ahmad Fawzi,Xiomara Fernandez,Robbie L. McLeod,(unknown),Hongtao Zhang	17
17	Synthesis and structure–activity relationships of 4-hydroxy-4-phenylpiperidines as nociceptin receptor ligands: Part 1 2007 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,(unknown),Deen Tulshian,William J. Greenlee,Ahmad Fawzi,(unknown),Hongtao Zhang	13
18	SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors 2001 ·Molecular Pharmacology ·Ahmad Fawzi,Douglas Macdonald,(unknown),April Smith‐Torhan,Hongtao Zhang,Blair Weig,Ginny D. Ho,Deen Tulshian,Maurine E. Linder,Michael P. Graziano	66
19	SCH-202676: An Allosteric Modulator of Both Agonist and Antagonist Binding to G Protein-Coupled Receptors 2001 ·Molecular Pharmacology ·Ahmad Fawzi,Douglas Macdonald,(unknown),April Smith‐Torhan,Hongtao Zhang,Blair Weig,Ginny D. Ho,Deen Tulshian,Maurine E. Linder,Michael P. Graziano	2
20	Synthesis and evaluation of potent and selective c-GMP phosphodiesterase inhibitors 1999 ·Bioorganic & Medicinal Chemistry Letters ·Ginny D. Ho,(unknown),(unknown),(unknown),Deen Tulshian,Yan Xia,Michael Czarniecki,Michael Green,(unknown),Hongtao Zhang,Ahmad Fawzi	10

About Ginny D. Ho

Ginny D. Ho is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology, having authored 22 papers that have together received 458 indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (14 papers), Neuropeptides and Animal Physiology (12 papers) and Pharmacological Receptor Mechanisms and Effects (5 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (193 citations), Pharmacology (93 citations) and Physiology (22 citations). Ginny D. Ho has collaborated with scholars based in United States, United Kingdom and Bulgaria. Frequent co-authors include Deen Tulshian, Ahmad Fawzi, Hongtao Zhang, William J. Greenlee, Robert A. Hodgson, April Smith‐Torhan, Shu‐Wei Yang, Michael P. Graziano, Zheng Tan and Xiaoping Zhang. Their work appears in journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Molecular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact